Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
J Clin Pharm Ther. 2022 Mar;47(3):330-344. doi: 10.1111/jcpt.13562. Epub 2021 Nov 4.
Paediatric intensive care patients are at high risk for prescription errors due to the more complex process of medication prescribing. Clinical decision support systems (CDSS) have shown good results in effectively reducing prescription errors. A specific dosing CDSS was developed that can check and suggest normal dose, dose limits and administration frequencies. This study aimed to assess the effect of this CDSS on protocol deviation (as measure of prescription error) types and frequency in a paediatric intensive care unit (PICU).
A retrospective observational study was conducted evaluating 9342 prescriptions in a 4-month period before and after the implementation of a CDSS in the PICU of the University Medical Center Utrecht. Medication forms were reviewed to identify protocol deviations (and therefore possible prescription errors). The incidence and nature of deviations from evidence-based protocols that were unintended and needed to be adjusted, were determined.
In the period before the dosing CDSS, we identified 45 protocol deviations in 5034 prescriptions (0.89%), 28 of which could not be justified (0.56%) and 11 needed to be adjusted (0.22%). In the period after the implementation of the CDSS, there were 21 protocol deviations in 4308 prescriptions (0.49%) of which ten without a valid reason (0.23%) of which two were adjusted (0.05%).
The specific dosing CDSS was able to significantly reduce unintentional prescription dose deviations and the number of prescriptions that needed to be adjusted, in an existing low incidence situation.
儿科重症监护病房的患者由于药物处方的过程更加复杂,因此存在较高的处方错误风险。临床决策支持系统(CDSS)在有效减少处方错误方面已显示出良好的效果。已经开发出一种特定的剂量 CDSS,可以检查并建议正常剂量、剂量限制和给药频率。本研究旨在评估该 CDSS 在乌得勒支大学医学中心儿科重症监护病房(PICU)中对方案偏差(作为处方错误的衡量标准)类型和频率的影响。
进行了一项回顾性观察性研究,评估了在 PICU 实施 CDSS 之前和之后的 4 个月内 9342 张处方。审查用药表以确定偏离证据为基础的方案(因此可能存在处方错误)。确定了需要调整的非预期和需要调整的偏离基于证据的方案的发生率和性质。
在使用剂量 CDSS 之前的时间段内,我们在 5034 张处方(0.89%)中发现了 45 个方案偏差,其中 28 个无法证明合理(0.56%),11 个需要调整(0.22%)。在实施 CDSS 之后的时间段内,在 4308 张处方(0.49%)中有 21 个方案偏差,其中 10 个没有合理的理由(0.23%),其中 2 个需要调整(0.05%)。
在现有的低发生率情况下,特定的剂量 CDSS 能够显著减少非故意的处方剂量偏差和需要调整的处方数量。